Literature DB >> 20602848

Assessment of early post-operative pain following septorhinoplasty.

P Szychta1, B Antoszewski.   

Abstract

OBJECTIVE: To evaluate pain incidence and intensity in patients undergoing septorhinoplasty, and to assess analgesic treatment effectiveness, in the first 7 days after surgery.
DESIGN: Prospective outcomes analysis using visual analogue scale assessment of pain intensity in the first 7 post-operative days.
SUBJECTS: Fifty-seven patients were enrolled in the study, 29 women and 28 men, aged 18 to 51 years. All were treated for post-traumatic deformity of the external nose and/or nasal septum, with either septorhinoplasty or septoplasty.
RESULTS: In the first 3 days after septorhinoplasty, patients' mean visual analogue scale pain score exceeded the range denoting 'analgesic success', and showed considerable exacerbation in the evening. Patients' pain decreased to a mean score of 15.4 one hour after administration of a nonsteroidal anti-inflammatory drug (metamizole).
CONCLUSION: Analgesia is recommended for all patients in the first 3 days after septorhinoplasty, especially in the early evening.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602848     DOI: 10.1017/S0022215110001519

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  A comparison of piezosurgery with conventional techniques for internal osteotomy.

Authors:  I Koçak; R Doğan; O Gökler
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-11       Impact factor: 2.503

2.  Postoperative pain assessment after septorhinoplasty.

Authors:  D Wittekindt; C Wittekindt; G Schneider; W Meissner; O Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-01       Impact factor: 2.503

3.  Nerve Block for Septorhinoplasty: A Retrospective Observational Study of Postoperative Complications in 24 Hours.

Authors:  Mohammed Elsayed; Razan A Alosaimy; Nujod Y Ali; Mohammad A Alshareef; Ahmed H Althqafi; Mohannad K Rajab; Abdullah S Assalem; Ahmed J Khiyami
Journal:  Cureus       Date:  2020-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.